You can buy or sell Tricida and other stocks, options, ETFs, and crypto commission-free!
Tricida, Inc. Common Stock, also called Tricida, is a pharmaceutical company, which focuses on the development and commercialization of its product, TRC101, a non-absorbed, orally-administered polymer drug designed to treat metabolic acidosis in patients with chronic kidney disease. Read More The company was founded by Gerrit Klaerner and Craig Jon Hawker in 2013 and is headquartered in South San Francisco, CA.
South San Francisco, California
52 Week High
52 Week Low
Tricida to Report Fourth Quarter and Full-Year 2018 Financial Results and Host Conference Call and Webcast on Thursday, March 28, 2019
SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--Tricida, Inc. (Nasdaq: TCDA) today announced that it will report its fourth quarter and the year ended December 31, 2018 financial results at 7:00 am Eastern Time on Thursday, March 28, 2019. Tricida will host a conference call and webcast at 8:00 am Eastern Time to discuss its financial results and business progress. The call or webcast may be accessed as follows: Tricida Fourth Quarter and Full-Year 2018 Conference Call Thursday, March 28, 2018 8:00 am Easter...
Tricida to Present at the Cowen and Company 39th Annual Health Care Conference
SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--Tricida, Inc. (Nasdaq: TCDA) today announced that it will present at the Cowen and Company 39th Annual Health Care Conference on Tuesday, March 12, 2019 at 8:20 am PT / 11:20 am ET. Geoff Parker, Tricida’s Chief Financial Officer, will provide a company overview, business update and progress on the company’s key initiatives. A live webcast of the presentation will be accessible on the Tricida website at IR.Tricida.com. An archive of the webcast will be availabl...
-$0.89 per share
Available Mar 28, Pre-Market